跳至主要内容
临床试验/NCT03084549
NCT03084549已完成3 期

Study of the Analgesic Effect of the Perineal Infiltration of Ropivacaine 0.75% Versus Placebo in Post-episiotomy Perineal Pain: a Randomized, Double-blind Study

Centre Hospitalier Departemental Vendee2 个研究点 分布在 1 个国家目标入组 272 人开始时间: 2017年10月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
272
试验地点
2
主要终点
Compare the analgesic efficacy of ropivacaine 75 mg infusion versus placebo (physiological saline) in patients with right mid-lateral episiotomy during postpartum D7 delivery.

研究概览

简要总结

Episiotomy is a common obstetric gesture (20 to 30% of deliveries by the low route). In postpartum, perineal pains associated with episiotomy are common, about 70% on D7 and persistent 13% at 5 months. Most studies of obstetrical analgesia have focussed on pain during labor or following a caesarean section. The perineal pain associated with the realization of an episiotomy has been much less studied and often undervalued.

Local ropivacaine has shown its effectiveness in the reduction of postoperative pain in many indications (wall surgery, hemorrhoidectomy, infiltration of trocar scars during laparoscopy). This product has the advantage of being well tolerated, easy access and administration. Three recent studies compared the post-episiotomy analgesic efficacy of local ropivacaine versus lidocaine versus placebo and lidocaine versus no infiltration. Two of these studies showed statistically significant results. However, they focused on the results at 24 and 48 hours and did not evaluate the analgesic efficacy in the medium and long term.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Major Patient (≥ 18 years)
  • Term ≥ 37 weeks of amenorrhea
  • Right medio-lateral episiotomy performed for medical need
  • Delivery of a single fetus in a cephalic presentation with or without instrumental extraction
  • Delivery under epidural anesthesia
  • Patient to be monitored over 6 months of study
  • Patient in ability to understand protocol
  • Patient having given consent and signed informed consent
  • Patient with social coverage

排除标准

  • Hypersensitivity or known allergy to Ropivacaine or to other amide-linked local anesthetics or to any of the excipients
  • General contraindication specific to local anesthesia, irrespective of the local anesthetic used
  • Contraindication for Ropivacaine- Obstetric paracervical anesthesia
  • Hypovolemia
  • Weight <50 kg
  • Contra-indication or refusal of the epidural
  • Poor understanding of the French language
  • Substance addiction.
  • Chronic pain syndrome.
  • Severe hepatic or renal impairment.
  • Acute porphyria.
  • Caesarean section programmed.
  • Tear of the 3rd degree according to the associated French classification.
  • Refusal to participate in the study
  • Patient under tutelage, curatorship, or deprived of liberty

研究组 & 干预措施

Ropivacaïne

Experimental

干预措施: Administration of Ropivacaïne (Drug)

Placebo

Placebo Comparator

干预措施: Administration of placebo (Drug)

结局指标

主要结局

Compare the analgesic efficacy of ropivacaine 75 mg infusion versus placebo (physiological saline) in patients with right mid-lateral episiotomy during postpartum D7 delivery.

时间窗: 7 days after episiotomy

Digital pain scale

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验